Compare Stocks: CNMD, MMSI, TFX, and HAE

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$47.09 +1.1%	$45.82	$31.44 ▼ $54.12	$1.40B	0.9	286,012 shs	262,292 shs
HAE Haemonetics	$103.06 +0.2%	$89.38	$47.31 ▼ $109.57	$4.68B	0.54	722,384 shs	612,214 shs
MMSI Merit Medical Systems	$87.19 -0.2%	$82.95	$59.74 ▼ $94.75	$5.22B	0.49	686,202 shs	475,565 shs
TFX Teleflex	$135.89 -0.8%	$135.82	$100.18 ▼ $145.00	$5.81B	0.82	549,857 shs	487,037 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	-4.82%	-5.26%	-4.86%	+28.28%	-13.33%
HAE Haemonetics	-0.18%	+0.83%	+17.49%	+30.45%	+90.32%
MMSI Merit Medical Systems	-2.48%	-3.64%	-1.86%	+30.44%	-5.36%
TFX Teleflex	-0.83%	-2.51%	+1.90%	+3.62%	+5.26%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$47.09 +1.1%	$45.82	$31.44 ▼ $54.12	$1.40B	0.9	286,012 shs	262,292 shs
HAE Haemonetics	$103.06 +0.2%	$89.38	$47.31 ▼ $109.57	$4.68B	0.54	722,384 shs	612,214 shs
MMSI Merit Medical Systems	$87.19 -0.2%	$82.95	$59.74 ▼ $94.75	$5.22B	0.49	686,202 shs	475,565 shs
TFX Teleflex	$135.89 -0.8%	$135.82	$100.18 ▼ $145.00	$5.81B	0.82	549,857 shs	487,037 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	-4.82%	-5.26%	-4.86%	+28.28%	-13.33%
HAE Haemonetics	-0.18%	+0.83%	+17.49%	+30.45%	+90.32%
MMSI Merit Medical Systems	-2.48%	-3.64%	-1.86%	+30.44%	-5.36%
TFX Teleflex	-0.83%	-2.51%	+1.90%	+3.62%	+5.26%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNMD CONMED	1.75	Reduce	$41.40	-12.09% Downside
HAE Haemonetics	2.73	Moderate Buy	$99.78	-3.18% Downside
MMSI Merit Medical Systems	2.83	Moderate Buy	$100.00	14.69% Upside
TFX Teleflex	2.42	Hold	$152.90	12.51% Upside

Current Analyst Ratings Breakdown

Latest CNMD, MMSI, TFX, and HAE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/3/2026	HAE Haemonetics	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$105.00 ➝ $125.00
8/25/2026	MMSI Merit Medical Systems	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/25/2026	TFX Teleflex	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$159.00 ➝ $170.00
8/21/2026	HAE Haemonetics	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$96.00 ➝ $119.00
8/19/2026	HAE Haemonetics	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$95.00 ➝ $118.00
8/18/2026	MMSI Merit Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/18/2026	HAE Haemonetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$96.00 ➝ $110.00
8/13/2026	MMSI Merit Medical Systems	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$92.00 ➝ $97.00
8/11/2026	HAE Haemonetics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/11/2026	TFX Teleflex	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$145.00 ➝ $158.00
8/11/2026	CNMD CONMED	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold

(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNMD CONMED	$1.37B	1.03	$6.87 per share	6.85	$33.36 per share	1.41
HAE Haemonetics	$1.35B	3.47	$7.59 per share	13.58	$17.14 per share	6.01
MMSI Merit Medical Systems	$1.52B	3.43	$5.72 per share	15.24	$26.72 per share	3.26
TFX Teleflex	$2.25B	2.55	$10.99 per share	12.36	$70.71 per share	1.92

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNMD CONMED	$47.06M	$1.85	25.45	9.96	2.25	4.12%	14.31%	6.33%	11/4/2026 (Estimated)
HAE Haemonetics	$97.31M	$2.04	50.52	17.99	2.06	7.12%	27.55%	9.65%	11/5/2026 (Estimated)
MMSI Merit Medical Systems	$128.49M	$2.42	36.03	20.91	2.24	9.22%	13.75%	8.10%	10/29/2026 (Estimated)
TFX Teleflex	-$905.64M	-$23.29	N/A	12.86	0.92	-39.67%	11.93%	5.44%	11/5/2026 (Estimated)

Latest CNMD, MMSI, TFX, and HAE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q1 2027	HAE Haemonetics	$1.08	$1.14	+$0.06	$0.72	$327.86 million	$339.38 million
8/6/2026	Q2 2026	TFX Teleflex	$1.28	$1.76	+$0.48	$2.28	$559.59 million	$570.33 million
7/30/2026	Q2 2026	MMSI Merit Medical Systems	$0.9590	$1.19	+$0.2310	$0.65	$405.25 million	$418.84 million
7/29/2026	Q2 2026	CNMD CONMED	$1.11	$1.38	+$0.27	$0.77	$337.60 million	$343.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNMD CONMED	$0.60	1.27%	-5.59%	32.43%	N/A
HAE Haemonetics	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.00%	N/A	N/A	N/A

Latest CNMD, MMSI, TFX, and HAE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	TFX Teleflex	quarterly	$0.34	0.99%	8/14/2026	8/14/2026	9/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNMD CONMED	0.63	1.48	0.69
HAE Haemonetics	1.40	3.08	1.91
MMSI Merit Medical Systems	0.44	4.20	2.79
TFX Teleflex	0.94	2.60	2.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNMD CONMED	N/A
HAE Haemonetics	99.67%
MMSI Merit Medical Systems	99.66%
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
CNMD CONMED	0.28%
HAE Haemonetics	2.07%
MMSI Merit Medical Systems	0.70%
TFX Teleflex	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNMD CONMED	3,900	29.95 million	29.87 million	Optionable
HAE Haemonetics	3,009	45.50 million	44.56 million	Optionable
MMSI Merit Medical Systems	7,500	59.71 million	59.29 million	Optionable
TFX Teleflex	15,500	42.37 million	42.08 million	Optionable

CNMD, MMSI, TFX, and HAE Headlines

Recent News About These Companies

Teleflex stock heads into the open after a 3.3 percent weekly gain

48 minutes ago | ad-hoc-news.deA

Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines

September 9 at 5:52 PM | finance.yahoo.com

Teleflex Incorporated Announces Appointment of Sean M. Salmon to Board of Directors and to the Growth and Operating Committee, Effective September 8, 2026

September 8 at 9:50 PM | marketscreener.comM

Medtronic veteran joins Teleflex’s board

September 8 at 9:50 PM | massdevice.com

Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors

September 8 at 6:48 AM | finance.yahoo.com

Public Employees Retirement System of Ohio Makes New Investment in Teleflex Incorporated $TFX

September 8 at 3:51 AM | marketbeat.com

Teleflex Inc. stock gains attention as new Dynetic-35 stent debuts at CIRSE 2026

September 6 at 9:55 AM | ad-hoc-news.deA

Teleflex Showcases Dynetic-35 Balloon-Expandable Cobalt Chromium Stent System At Cirse 2026

September 5, 2026 | marketscreener.comM

Teleflex (TFX): Guidance Cut Meets A Bigger Buyback Push

September 5, 2026 | finance.yahoo.com

Teleflex Sinks ahead of Copenhagen Show

September 4, 2026 | baystreet.ca

Teleflex To Showcase Dynetic-35 Stent System At CIRSE 2026

September 4, 2026 | rttnews.com

Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026

September 4, 2026 | businesswire.com

Teleflex (TFX): Guidance Cut Meets A Bigger Buyback Push

September 4, 2026 | insidermonkey.com

Man Group plc Takes $1.69 Million Position in Teleflex Incorporated $TFX

September 2, 2026 | marketbeat.com

Corient Private Wealth LP Acquires Shares of 23,715 Teleflex Incorporated $TFX

September 2, 2026 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Sees Large Increase in Short Interest

August 31, 2026 | marketbeat.com

Newtyn Management LLC Reduces Stake in Teleflex Incorporated $TFX

August 31, 2026 | marketbeat.com

Moore Capital Management LP Sells 52,475 Shares of Teleflex Incorporated $TFX

August 31, 2026 | marketbeat.com

104,328 Shares in Teleflex Incorporated $TFX Acquired by Legal & General Group Plc

August 31, 2026 | marketbeat.com

Freestone Grove Partners LP Takes $9.07 Million Position in Teleflex Incorporated $TFX

August 29, 2026 | marketbeat.com

Bank of New York Mellon Corp Invests $33.36 Million in Teleflex Incorporated $TFX

August 29, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD, MMSI, TFX, and HAE Company Descriptions

CONMED NYSE:CNMD

$47.09 +0.50 (+1.08%)

Closing price 03:59 PM Eastern

Extended Trading

$46.95 -0.14 (-0.30%)

As of 07:30 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Haemonetics NYSE:HAE

$103.06 +0.22 (+0.21%)

Closing price 03:59 PM Eastern

Extended Trading

$103.12 +0.06 (+0.06%)

As of 07:30 PM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Merit Medical Systems NASDAQ:MMSI

$87.19 -0.19 (-0.22%)

Closing price 04:00 PM Eastern

Extended Trading

$85.48 -1.71 (-1.96%)

As of 07:30 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Teleflex NYSE:TFX

$135.89 -1.11 (-0.81%)

Closing price 03:59 PM Eastern

Extended Trading

$135.77 -0.12 (-0.09%)

As of 07:30 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CNMD, MMSI, TFX, and HAE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CNMD, MMSI, TFX, and HAE Earnings

Compare Dividends

Latest CNMD, MMSI, TFX, and HAE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CNMD, MMSI, TFX, and HAE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD, MMSI, TFX, and HAE Company Descriptions

CONMED NYSE:CNMD

Haemonetics NYSE:HAE

Merit Medical Systems NASDAQ:MMSI

Teleflex NYSE:TFX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CNMD, MMSI, TFX, and HAE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CNMD, MMSI, TFX, and HAE Earnings

Compare Dividends

Latest CNMD, MMSI, TFX, and HAE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CNMD, MMSI, TFX, and HAE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD, MMSI, TFX, and HAE Company Descriptions

CONMED NYSE:CNMD

Haemonetics NYSE:HAE

Merit Medical Systems NASDAQ:MMSI

Teleflex NYSE:TFX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools